Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 23081842)

1.

Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season.

Samuelsson U, Lindblad B, Carlsson A, Forsander G, Ivarsson S, Kockum I, Lernmark Å, Marcus C, Ludvigsson J; Better Diabetes Diagnosis study group.

Diabetes Metab Res Rev. 2013 Jan;29(1):85-9. doi: 10.1002/dmrr.2365.

2.

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.

Mortensen HB, Swift PG, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, de Beaufort CE, Knip M; Hvidoere Study Group on Childhood Diabetes.

Pediatr Diabetes. 2010 Jun;11(4):218-26. doi: 10.1111/j.1399-5448.2009.00566.x. Epub 2008 Aug 25.

PMID:
19708904
3.

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

Horm Metab Res. 2006 Oct;38(10):668-72.

PMID:
17075776
4.

C-peptide in the classification of diabetes in children and adolescents.

Ludvigsson J, Carlsson A, Forsander G, Ivarsson S, Kockum I, Lernmark A, Lindblad B, Marcus C, Samuelsson U.

Pediatr Diabetes. 2012 Feb;13(1):45-50. doi: 10.1111/j.1399-5448.2011.00807.x. Epub 2011 Sep 13.

PMID:
21910810
5.

Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.

Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL.

Diabetes Technol Ther. 2011 Oct;13(10):1023-30. doi: 10.1089/dia.2011.0085. Epub 2011 Jun 30.

PMID:
21718094
6.

[Factors affecting C-peptide level during the first year of type 1 diabetes in children].

Zmysłowska A, Szadkowska A, Andrzejewski W, Wegner O, Wyka K, Młynarski W, Bodalski J.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):103-11. Polish.

PMID:
15504313
7.

Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five.

Szypowska A, Stelmaszczyk-Emmel A, Demkow U, Luczyński W.

Arch Immunol Ther Exp (Warsz). 2012 Aug;60(4):307-13. doi: 10.1007/s00005-012-0177-y. Epub 2012 Jun 9.

PMID:
22684085
8.

Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes.

Weets I, Truyen I, Verschraegen I, Van der Auwera B, De Schepper J, Dorchy H, Lebrethon MC, Van Gaal L, Van Rooy P, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2006 Jun;49(6):1158-62. Epub 2006 Mar 29.

PMID:
16570164
9.

Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.

Tung YC, Lee JS, Tsai WY, Hsiao PH.

Eur J Pediatr. 2008 Jul;167(7):801-5. Epub 2007 Sep 15.

PMID:
17874132
10.

[The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].

Szadkowska A, Pietrzak I, Markuszewski L, Bodalski J.

Med Wieku Rozwoj. 2005 Apr-Jun;9(2):223-34. Polish.

PMID:
16085963
11.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
12.

Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.

Böber E, Dündar B, Büyükgebiz A.

J Pediatr Endocrinol Metab. 2001 Apr;14(4):435-41.

PMID:
11327378
13.

Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.

PMID:
11822582
14.
15.

[Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood].

Młynarski W, Zmysłowska A, Kubryn I, Perenc M, Bodalski J.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(1):23-8. Polish.

PMID:
12831634
16.

Residual β-cell mass influences growth of prepubertal children with type 1 diabetes.

Bizzarri C, Benevento D, Patera IP, Bongiovanni M, Boiani A, Fusco C, Cianfarani S, Cappa M.

Horm Res Paediatr. 2013;80(4):287-92. doi: 10.1159/000355116. Epub 2013 Sep 18.

PMID:
24051686
17.
19.

Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.

Samuelsson U, Ludvigsson J, Bottazzo GF, Shattock M, Adolfsson S, Becker D, Cacciari E, Chiarelli F, Chiumello G, Deschamps I, et al.

Acta Diabetol. 1994 Jun;31(2):107-15.

PMID:
7949221
20.

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

Diabetes. 2008 Apr;57(4):929-37. doi: 10.2337/db07-1697. Epub 2008 Feb 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk